The Efficacy and Safety of Intranasal Formulations of Ketamine and Esketamine for the Treatment of Major Depressive Disorder: A Systematic Review

• Principais autores: Ludivine Boudieu (Autor), Myriam Mennetrier (Autor), Pierre-Michel Llorca (Autor), Ludovic Samalin (Autor)
• Formato: Livro
• Publicado em: MDPI AG, 2023-12-01T00:00:00Z.
• Assuntos: article
• Acesso em linha: Connect to this object online.

Ketamine and its enantiomers represent an innovative glutamatergic agent as a treatment for individuals with treatment-resistant depression (TRD) and major depressive disorder (MDD) with suicidal ideation and behavior. Intranasal (IN) formulations could allow for quick onset of action on depressive...